Compare AMRX & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | TPH |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | 2018 | 2012 |
| Metric | AMRX | TPH |
|---|---|---|
| Price | $12.78 | $46.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $15.60 | ★ $45.75 |
| AVG Volume (30 Days) | 1.4M | ★ 2.1M |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | N/A |
| EPS | 0.22 | ★ 2.72 |
| Revenue | N/A | ★ $3,260,447,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.13 | $10.20 |
| P/E Ratio | $57.57 | ★ $17.25 |
| Revenue Growth | N/A | ★ 5.76 |
| 52 Week Low | $7.02 | $28.72 |
| 52 Week High | $15.42 | $46.99 |
| Indicator | AMRX | TPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 70.63 |
| Support Level | $12.50 | $46.24 |
| Resistance Level | $12.85 | $46.99 |
| Average True Range (ATR) | 0.49 | 0.06 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 30.56 | 53.19 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. Its financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.